National Heart, Lung and Blood Institute (NHLBI) — Bethesda, Maryland

Public research footprint of National Heart, Lung and Blood Institute (NHLBI), compiled from the ClinicalTrials.gov public registry.

122

Registered studies

Active

Recruiting now

118

Completed

Stopped or withdrawn

Most-studied conditions

Sickle Cell Disease · Coronary Artery Disease · Myocardial Ischemia · Severe Aplastic Anemia

Recently updated registry entries

NCT06948097 — Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the… (Not Yet Recruiting)
NCT02290392 — Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0 (Completed)
NCT05031780 — A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Heart, Lung and Blood Institute (NHLBI)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.